Early Access — free while we kick the tires
EdgarHawk

MOBI Mobia Medical, Inc. Insider Trading

Latest: Insider Bought $8.0M of Shares · May 2026

Multiple insiders have been active at Mobia Medical, Inc. (MOBI): 9 distinct insiders account for 10 buy filings and 0 sell filings as of Jun 2026. Its highest-significance filing in the last 90 days: Llc Osage University Gp Iii bought $8.0M, transaction dated May 2026.

10 filings analyzed · Latest 2026-06-29

Get alerts for MOBI

Free Form 4 email alerts, scored for significance — see how.

Buys
10
Sells
0
Insiders
9
Direction
Net buying

Mobia Medical, Inc. leadership

CEO
Richard Foust — Chief Executive Officer
CFO
Bunker Curnes — Chief Financial Officer
June 2026
2026-06-29
low
60,537 shares
$908,055
@ $15.00
Significance 3

Green Park & Golf Ventures acquired 60,537 shares of MOBI at $15.00 via private placement totaling $908,055.00

Green Park & Golf Ventures, a 10% owner, acquired 60,537 shares at $15.00 on 2026-05-11 through a private placement, not a discretionary open-market purchase. The company's recent quarterly revenue stands at $12,074,000.00 against a net loss of $17,740,000.00, indicating ongoing profitability challenges that constrain the signal value of this allocation. The current stock price of $14.38 trades 6.0% below the 52-week high of $15.29 and has risen 9.8% over the past 30 days, placing the transaction timing relative to recent momentum. As a private placement allocation to an existing investor rather than a voluntary open-market acquisition, this transaction reflects an investment opportunity presented to the shareholder class rather than insider discretionary conviction.

2026-06-29
low
33,333 shares
$499,995
@ $15.00
Significance 4

Green Park & Golf Ventures II, LLC purchases 33,333 shares ($500.0K) of MOBI via private placement at $15.00

Green Park & Golf Ventures II, LLC, a 10% owner, acquired 33,333 shares for $499,995.00 in a private placement transaction, increasing its holding by 12.0% to 311,112 shares post-transaction. Per the FLAG, this is not a discretionary open-market purchase but rather an allocated position in a structured financing vehicle (PIPE, registered direct, or similar), so the acquisition should not be interpreted as evidence of insider conviction or a buying signal. The derivative holdings table shows zero remaining positions across all 11 security lines post-transaction, indicating all prior derivative securities have fully converted or been exercised. The company reported $12.1M in quarterly revenue but a $-17.7M net loss, and the stock currently trades at $14.38, down 6.0% from the 52-week high of $15.29 against a market cap of $478.1M. The transaction occurred at a price within the 52-week range, and the +12.0% increase in the filer's non-derivative holdings reflects the mechanical result of the allocation rather than a discretionary positioning decision.

2026-06-29
low
81,000 shares
$1,215,000
@ $15.00
Significance 3

Green Park & Golf Ventures II acquired 81,000 shares of MOBI at $15.00 in private placement worth $1.2M

Green Park & Golf Ventures II, a 10% owner, purchased 81,000 shares at $15.00 per share ($1.2M total) on 2026-05-11 as part of a private placement, not an open-market discretionary purchase. The transaction occurs near the stock's 52-week high of $15.29, with the current price at $14.38, representing -6.0% from the high. The company is unprofitable with net income of $-17.7M against quarterly revenue of $12.1M, and the market cap stands at $478.1M. As a private placement allocation, this transaction does not reflect discretionary insider conviction but rather structured capital participation.

2026-06-11
low
Chief Financial Officer
5,000 shares
$63,969
@ $12.79
Significance 3

CFO Nelson Bunker Curnes bought 5,000 shares of MOBI at $12.79 via private placement allocation.

Nelson Bunker Curnes, Chief Financial Officer of Mobia Medical, acquired 5,000 shares at $12.79 on 2026-06-09 through a private placement—a structured capital event, not a discretionary open-market purchase that would reflect personal conviction. The company is unprofitable with a latest-quarter net income of $-17.7M against revenue of $12.1M, and the stock is in early trading (23 days post-IPO), making historical valuation context unavailable. His post-transaction holdings of 367.0K shares represent an increase of only 1.4% relative to his prior 362.0K-share position, a modest change consistent with pro-rata participation in an IPO-stage capital round rather than an aggressive accumulation signal. This transaction reflects participation in a structured financing vehicle and provides limited insight into insider conviction in the company's fundamentals.

May 2026
2026-05-12 Cluster
high
533,333 shares
$7,999,995
@ $15.00
Significance 7

Osage University GP III acquires 3.4M shares via conversions and open-market buys; 10% owner joins 5 other insiders buying within two weeks of IPO.

Osage University GP III, a 10% institutional shareholder, deployed substantial capital to acquire over 3.4 million shares on the day of this filing, combining stock conversions with open-market purchases at the company's current trading price. This institutional activity coincides with a broader pattern: five other insiders have also purchased shares within a two-week window around the IPO, suggesting broad appetite for Mobia Medical's stock among major stakeholders at or near its listing price. As a fund rather than an officer or director, Osage's activity reflects portfolio management decisions rather than insider operational knowledge, but the coincidence of multiple 10% holders and other insiders buying into a newly listed company is noteworthy. The stock has virtually no trading history beyond the IPO, making price context limited, and fundamental data is absent from the filing. The sheer volume of this institutional acquisition—coupled with the cluster of other insider buying—indicates significant capital flow into the company during its earliest public trading days.

2026-05-11 Cluster
high
66,666 shares
$999,990
@ $15.00
Significance 7

Director Tansey Casey M acquires nearly 3.9M shares in open-market purchase, part of a five-insider buying wave within a 14-day window at newly listed company.

Director Tansey Casey M, who is also a 10% beneficial owner, made a substantial open-market purchase of nearly 3.9 million shares on the company's second day of trading. The transaction includes one open-market purchase at $15 per share (worth just under $1 million) plus three stock conversions, significantly expanding his ownership stake. This purchase arrives as part of a broader pattern: five insiders bought shares within a 14-day window, suggesting multiple company stakeholders saw value at the current price level. The stock is trading modestly above its listing price on a newly public company with only one prior day of trading history, making price-context analysis difficult. Tansey's track record as a buyer shows a positive 30-day return on his prior open-market purchase but a negative 90-day return, indicating mixed timing results on his previous acquisition.

2026-05-11 Cluster
high
533,333 shares
$7,999,995
@ $15.00
Significance 7

Director and 10% owner Harrington acquires 3.4M shares via open-market purchases and conversions; three insiders buying within 14-day window.

William T Harrington, a director and 10% beneficial owner of Mobia Medical, executed a substantial acquisition of over 3.4 million shares on a single date through both open-market purchases and warrant conversions. This is Harrington's first open-market purchase activity in the available filing history, marking a notable shift into accumulation. The acquisition occurs alongside two other insiders purchasing shares within the same 14-day window, creating a pattern of multiple insiders deploying capital at the same time. The stock is trading above its 52-week low, recently listed, making this early-stage buying activity notable in terms of timing and scale relative to his existing ownership stake.

2026-05-11 Cluster
high
125,000 shares
$1,875,000
@ $15.00
Significance 7

Director Lucchese buys 125,000 shares for $1.875M on day of IPO; 4 insiders buying in same window.

Lucchese Cynthia L, a director of Mobia Medical, purchased 125,000 shares at the IPO price on the company's first trading day as part of a broader wave of insider buying—four insiders bought open-market shares within a two-week window. This represents her second open-market purchase in the 36-month tracking window, following a prior buy that subsequently declined; her historical track record shows purchases that have not appreciated after acquisition. The timing is notable: she is buying at the IPO price itself rather than waiting for secondary trading, and the cluster of director-level purchases on the opening trading day is unusual. Without longer trading history or financial fundamentals available, the significance of this trade depends on how Mobia's stock performs after listing and whether this wave of director purchases reflects underlying confidence in the company's prospects or merely represents pre-planned IPO allocations.

2026-05-11
high
See Remarks
3,000 shares
$45,000
@ $15.00
Significance 7

Officer Leavitt makes first open-market purchase of 3,000 shares at $15, marking departure from stock-comp-only activity.

Leavitt Chase C., an officer at Mobia Medical, deployed personal capital to purchase 3,000 shares at $15 on the company's filing date. This is significant because it marks the first time this insider has bought shares on the open market—all prior Form 4 activity in the 36-month window consisted of stock-based compensation transactions. The transition from receiving equity as part of compensation to voluntarily purchasing shares with personal funds is a meaningful behavioral shift. Given the company is newly listed with minimal trading history, price context is limited, but the willingness to buy into a recently public company suggests this officer sees enough value to make an out-of-pocket commitment. Without longer-term pricing or performance data, the full significance of this purchase relative to the IPO price remains unclear.

2026-05-11
high
7,000 shares
$105,000
@ $15.00
Significance 7

Director Dana G Mead Jr. buys 7,000 shares of MOBI in first open-market purchase after prior stock-based compensation activity.

Director Dana G Mead Jr. deployed personal capital to acquire 7,000 shares on the open market, marking a shift from receiving stock through compensation arrangements to making an active open-market purchase decision. This is his first open-market buy in the 36-month window, distinguishing the trade from the nine prior stock-based compensation transactions on his record. The purchase occurred while the stock trades near its recent trading range, with the broader context that MOBI is a newly listed company with limited trading history. A director buying with personal capital—rather than exercising or disposing of granted shares—typically reflects a view that the current valuation warrants direct investment, though the transaction alone does not indicate financial health or near-term catalysts.

Insiders here also file at

More Measuring and Controlling Instruments companies